Pathfinder Cell Therapy, Inc. (PFND)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Dec 29, 2025
Pathfinder Cell Therapy Market Cap
Pathfinder Cell Therapy has a market cap or net worth of $667 as of August 5, 2026.
Market Cap
667.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since September 6, 2011, Pathfinder Cell Therapy's market cap has decreased from 550.00K to 667.00, a decrease of -99.88%. That is a compound annual growth rate of -37.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 667.00 | - |
| Dec 30, 2022 | 667.00 | -99.95% |
| Dec 31, 2020 | 1.27M | -9.52% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TetraLogic Pharmaceuticals | 973.00 |
| eFFECTOR Therapeutics | 941.00 |
| RegeneRx Biopharmaceuticals | 905.00 |
| U.S. Stem Cell | 662.00 |
| Proteonomix | 633.00 |
| Amarantus BioScience Holdings | 630.00 |
| Alzex Neuropharma | 602.00 |
| Mera Pharmaceuticals | 537.00 |